Folks with asthma might better control their symptoms by precisely timing when they use their inhaler, a new study says.

Sanofi (NASDAQ:SNY) announced Tuesday that its TIDE-Asthma Phase 2 study for its T-cell-depleting monoclonal antibody ...

You're also at a higher risk if you have a family history of anaphylaxis or have asthma. Anaphylaxis and its symptoms usually happen in stages. But it can worsen fast. Your symptoms are likely ...

Among the children studied, 12.3 percent had asthma at the time of their 4- to 6-year checkup and 15.8 percent had wheezing.

The Asthma and Allergy Foundation of America has ... The report ranks the top 100 U.S. cities based on pollen levels, over-the-counter allergy medication use and access to allergists.

Climate change is causing a notable increase in pediatric asthma cases due to rising air pollution, temperatures, and ...

Analysts at Leerink agreed with Sanofi that, despite falling short of statistical significance in the Phase II TIDE-Asthma trial, amlitelimab warrants further development in this indication.